4578.T
Otsuka Holdings Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 12,240.00
+0.41%Year over year
Reported trailing growth
- Revenue
- +5.1%
- EBITDA
- —
- EBIT
- +35.2%
- EPS
- +9.4%
- Free cash flow
- -5.9%
- Operating cash flow
- -3.9%
Forward estimates
Based on analyst estimates
- Revenue
- +0.1%
- EBITDA
- —
- EPS
- -28.9%
Three-year CAGR
- Revenue
- +12.4%
- EBITDA
- +34.6%
- EBIT
- +47.2%
- Net income
- +39.4%
- EPS
- +40.5%
- Free cash flow
- +27.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026